Chief Executive Officer
A strong scientific background with over 30 years experience in the pharmaceutical and life sciences industry within the UK, Europe and the United States of America.
From a multidisciplinary background including five years in academic research, three years applied pharmaceutical research and management with Ciba-Geigy, and 28 years commercial and general management experience with SmithKline Beecham plc, Amersham plc, Core Group plc, Oxford Asymmetry plc, Synaptica Ltd, Scancell Ltd and Hunter-Fleming Ltd. A broad working knowledge of the biopharmaceutical industry with a strong commercial bias, combined with a solid understanding of pharmaceutical discovery and development. First hand experience of raising capital from private and public markets to fund early stage biotechnology companies (over £35M raised since 1997) including an IPO of Core Group as a full listing on the London Stock Exchange (LSE) in 1997.
Specialties: IPO experience; private venture fund raising; general management; regional and strategic marketing; sales management; business development with considerable in- and out-licensing experience